1. Volume 14, Issue 5, Pages 702-709 (May 2017)
Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study 
Gabor Z. Duray, MD, PhD, Philippe Ritter, MD, Mikhael El-Chami, MD, FHRS, Calambur Narasimhan, MD, Razali Omar, MD, FHRS, Jose M. Tolosana, MD, PhD, Shu Zhang, MD, FHRS, Kyoko Soejima, MD, Clemens Steinwender, MD, Leonardo Rapallini, MScEng, Aida Cicic, MD, Dedra H. Fagan, PhD, Shufeng Liu, MS, Dwight Reynolds, MD, FHRS 
Heart Rhythm 
Volume 14, Issue 5, Pages (May 2017)
DOI: /j.hrthm
Copyright © 2017 The Authors Terms and Conditions

2. Figure 1
Major complication rate through 18 months postimplant for Micra and transvenous control cohorts. Subdistributional hazard ratio derived from data through 365 days postimplant for each cohort by comparing the cumulative incidence functions to the left of the dashed line. CI = confidence interval; HR = hazard ratio.
Heart Rhythm  , DOI: ( /j.hrthm )
Copyright © 2017 The Authors Terms and Conditions

3. Figure 2
Risk of major complications through 12 months postimplant comparing Micra data set with reference data set in subgroups. The vertical solid line corresponds to equal risk. The vertical dashed line represents the subdistributional hazard ratio from the full comparison. The horizontal solid lines represent the 95% confidence intervals for the hazard ratios. COPD = chronic obstructive pulmonary disease; LBBB = left bundle branch block.
Heart Rhythm  , DOI: ( /j.hrthm )
Copyright © 2017 The Authors Terms and Conditions

4. Figure 3
Micra electrical parameters by study visit. Data in the graphs are mean values. The vertical solid lines represent the SD. N values are the numbers of patients for whom data were available at each study visit. PHD = Pre-hospital discharge.
Heart Rhythm  , DOI: ( /j.hrthm )
Copyright © 2017 The Authors Terms and Conditions